Edwards Lifesciences Corporation
MX ˙ BMV ˙ US28176E1082
SecurityMX:EW / Edwards Lifesciences Corporation
InstitutionAaron Wealth Advisors LLC
Latest Disclosed Ownership9,374 shares
Latest Disclosed Value $ 750,670
Aaron Wealth Advisors LLC reports 0.16% decrease in ownership of EW / Edwards Lifesciences Corporation

On April 21, 2026 - Aaron Wealth Advisors LLC filed a 13F-HR form disclosing ownership of 9,374 shares of Edwards Lifesciences Corporation (MX:EW) valued at $750,670 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 21, 2026 disclosing 9,389 shares of Edwards Lifesciences Corporation. This represents a change in shares of -0.16% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-21 2026-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 9,374 -15 -0.16 751 -6.25 0.0426
2026-01-21 2025-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 9,389 -98 -1.03 800 8.55 0.0437
2025-10-03 2025-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 9,487 3,484 58.04 738 57.14 0.0437
2025-07-09 2025-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 6,003 390 6.95 469 15.52 0.0480
2025-04-28 2025-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 5,613 -675 -10.73 407 -12.69 0.0466
2025-01-15 2024-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 6,288 2,155 52.14 466 70.96 0.0540
2024-10-17 2024-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 4,133 4,133 273 0.0325
2023-10-19 2023-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 0 -3,262 -100.00 0 -100.00
2023-07-26 2023-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 3,262 405 14.18 308 30.08 0.0400
2023-05-02 2023-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 2,857 2,857 236 0.0325
2023-01-24 2022-12-31 13F Edwards Lifesciences COM 28176E108 0 -2,967 -100.00 0 -100.00
2022-10-21 2022-09-30 13F Edwards Lifesciences COM 28176E108 2,967 839 39.43 245 21.29 0.0452
2022-07-22 2022-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 2,128 -261,329 -99.19 202 -90.97 0.0508
2022-05-10 2022-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 263,457 261,191 11,526.52 2,238 663.82 0.0310
2022-01-21 2021-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 2,266 277 13.93 293 30.22 0.0819
2021-10-21 2021-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 1,989 1,989 225 0.0634
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.